Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 108,460 | 56,390 | 87,467 | 114,374 | 100,162 |
Cost of Goods | 32,383 | 21,140 | 26,920 | 33,116 | 30,222 |
Gross Profit | 76,077 | 35,250 | 60,547 | 81,258 | 69,940 |
Operating Expenses | 80,009 | 70,751 | 84,534 | 93,055 | 86,146 |
Operating Income | -3,549 | -35,361 | -23,067 | -11,681 | -15,984 |
Interest Expense | 6,363 | 6,122 | 2,826 | 2,778 | 2,755 |
Other Income | 135 | 464 | 1,311 | 1,198 | 1,312 |
Pre-tax Income | -9,777 | -41,019 | -24,582 | -13,261 | -17,427 |
Income Tax | 208 | 44 | 306 | 481 | 420 |
Net Income Continuous | -9,985 | -41,063 | -24,888 | -13,742 | -17,847 |
Net Income | $-9,985 | $-41,063 | $-24,888 | $-13,742 | $-17,847 |
EPS Basic Total Ops | -0.29 | -1.21 | -0.78 | -0.43 | -0.58 |
EPS Basic Continuous Ops | -0.29 | -1.21 | -0.78 | -0.42 | -0.58 |
EPS Diluted Total Ops | -0.29 | -1.21 | -0.78 | -0.43 | -0.58 |
EPS Diluted Continuous Ops | -0.29 | -1.21 | -0.78 | -0.42 | -0.58 |
EBITDA(a) | $2,955 | $-27,051 | $-21,066 | $-1,941 | $-14,502 |